Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

[Collagen synthesis and heart failure].

Jiménez-Navarro MF, Gómez-Doblas JJ, Cabrera-Bueno F, Cruz-Ocaña E, Rodríguez-Bailón I, Ruiz-Galdón M, Morell M, Molero E, de Teresa-Galván E.

Rev Esp Cardiol. 2005 Aug;58(8):975-8. Spanish.

2.

Relation of circulating markers of fibrosis and progression of left and right ventricular dysfunction in hypertensive patients with heart failure.

Plaksej R, Kosmala W, Frantz S, Herrmann S, Niemann M, Störk S, Wachter R, Angermann CE, Ertl G, Bijnens B, Weidemann F.

J Hypertens. 2009 Dec;27(12):2483-91. doi: 10.1097/HJH.0b013e3283316c4d.

PMID:
19887955
4.

Procollagen type I carboxy-terminal peptide shows left ventricular hypertrophy and diastolic dysfunction in hypertensive patients.

Demir M, Acartürk E, Inal T, Attila G, Dönmez Y, Avkaroğullari M, Cayli M.

Cardiovasc Pathol. 2007 Mar-Apr;16(2):69-74.

PMID:
17317538
5.

Serum carboxy-terminal telopeptide of type I collagen (ICTP) predicts cardiac events in chronic heart failure patients with preserved left ventricular systolic function.

Kitahara T, Takeishi Y, Arimoto T, Niizeki T, Koyama Y, Sasaki T, Suzuki S, Nozaki N, Hirono O, Nitobe J, Watanabe T, Kubota I.

Circ J. 2007 Jun;71(6):929-35.

6.

Low synthesis rate of type I procollagen is normalized during active back rehabilitation.

Hupli M, Hurri H, Luoto S, Risteli L, Vanharanta H, Risteli J.

Spine (Phila Pa 1976). 1997 Apr 15;22(8):850-4.

PMID:
9127916
7.

Low serum levels of intact osteocalcin in patients with congestive heart failure.

Schleithoff SS, Zittermann A, Stüttgen B, Tenderich G, Berthold HK, Körfer R, Stehle P.

J Bone Miner Metab. 2003;21(4):247-52.

PMID:
12811631
8.

Serum carboxy-terminal cross-linked telopeptide of type I collagen reflects bone metastasis in hepatocellular carcinoma.

Ueno T, Hashimoto O, Sugawara H, Ogata R, Kusaba N, Torimura T, Sata M, Tanikawa K.

Int J Oncol. 1998 Aug;13(2):297-303.

PMID:
9664125
10.

Diurnal variation in serum markers of type I collagen synthesis and degradation in healthy premenopausal women.

Hassager C, Risteli J, Risteli L, Jensen SB, Christiansen C.

J Bone Miner Res. 1992 Nov;7(11):1307-11.

PMID:
1466255
11.

Serum carboxy-terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease.

Querejeta R, Varo N, López B, Larman M, Artiñano E, Etayo JC, Martínez Ubago JL, Gutierrez-Stampa M, Emparanza JI, Gil MJ, Monreal I, Mindán JP, Díez J.

Circulation. 2000 Apr 11;101(14):1729-35.

12.

Usefulness of serum carboxy-terminal propeptide of procollagen type I in assessment of the cardioreparative ability of antihypertensive treatment in hypertensive patients.

López B, Querejeta R, Varo N, González A, Larman M, Martínez Ubago JL, Díez J.

Circulation. 2001 Jul 17;104(3):286-91.

13.

Serum carboxy-terminal propeptide of type I procollagen (PIP) is a marker of diastolic dysfunction in patients with early type 2 diabetes mellitus.

Ihm SH, Youn HJ, Shin DI, Jang SW, Park CS, Kim PJ, Kim HY, Chang K, Seung KB, Kim JH, Choi KB.

Int J Cardiol. 2007 Nov 30;122(3):e36-8.

PMID:
17920710
14.

Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction.

Martos R, Baugh J, Ledwidge M, O'Loughlin C, Conlon C, Patle A, Donnelly SC, McDonald K.

Circulation. 2007 Feb 20;115(7):888-95. Epub 2007 Feb 5.

15.

Transforming growth factor beta in hypertensives with cardiorenal damage.

Laviades C, Varo N, Díez J.

Hypertension. 2000 Oct;36(4):517-22.

16.

Collagen type-I degradation is related to arterial stiffness in hypertensive and normotensive subjects.

McNulty M, Mahmud A, Spiers P, Feely J.

J Hum Hypertens. 2006 Nov;20(11):867-73. Epub 2006 Apr 6.

PMID:
16598292
17.

Biochemical markers of type III and I collagen: association with retinopathy and neuropathy in type 1 diabetic subjects.

Arkkila PE, Rönnemaa T, Koskinen PJ, Kantola IM, Seppänen E, Viikari JS.

Diabet Med. 2001 Oct;18(10):816-21.

PMID:
11678972
18.

Circulating type I collagen degradation products: a new serum marker for clinical severity in patients with scleroderma?

Hunzelmann N, Risteli J, Risteli L, Sacher C, Vancheeswaran R, Black C, Krieg T.

Br J Dermatol. 1998 Dec;139(6):1020-5.

PMID:
9990365
19.
20.

Biochemical markers of types I and III collagen and limited joint mobility in type 1 diabetic patients.

Arkkila PE, Koskinen PJ, Kantola IM, Rönnemaa T, Seppänen E, Viikari JS.

Acta Diabetol. 2003 Dec;40(4):151-5.

PMID:
14740273

Supplemental Content

Support Center